LABP-104
- Generic Name
- LABP-104
Safety Tolerability and Pharmacokinetics of Oral NIM-1324 in Healthy Adult Male and Female Volunteers
- First Posted Date
- 2021-08-25
- Last Posted Date
- 2023-06-08
- Lead Sponsor
- NImmune Biopharma
- Target Recruit Count
- 56
- Registration Number
- NCT05019950
- Locations
- 🇦🇺
Clinical Site, Herston, Queensland, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath